Skip to main content
HR 2805 114th Congress House Health Advisory bodies Civil actions and liability Congressional oversight Crime prevention Drug therapy Drug trafficking and controlled substances Drug, alcohol, tobacco use Emergency medical services and trauma care First responders and emergency personnel Government information and archives Health information and medical records Health programs administration and funding Health promotion and preventive care Law enforcement administration and funding Medical research Prescription drugs State and local government operations

Heroin and Prescription Opioid Abuse Prevention, Education, and Enforcement Act of 2015

Introduced: June 17, 2015 See on congress.gov
Sign in to write a letter Sign in to watch
 Everywhere this bill has been 4 steps
Introduced
In committee
Reported out
Passed House
Passed Senate
To President
Became law
Jul 9, 2015
Referred to the Subcommittee on Crime, Terrorism, Homeland Security, and Investigations.
Jun 19, 2015
Referred to the Subcommittee on Health.
Jun 17, 2015
Referred to the Committee on Energy and Commerce, and in addition to the Committee on the Judiciary, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Jun 17, 2015
Introduced in House
 Plain-English summary Congressional Research Service

Heroin and Prescription Opioid Abuse Prevention, Education, and Enforcement Act of 2015

This bill requires the Department of Health and Human Services (HHS), in cooperation with the Department of Veterans Affairs, the Department of Defense, and the Drug Enforcement Administration (DEA), to convene a Pain Management Best Practices Inter-Agency Task Force to develop and study best practices for pain management and prescription of pain medication.

This bill amends the Public Health Service Act to revise and extend through FY2020 the controlled substance monitoring program.

Government entities receiving nonidentifiable information from a controlled substance monitoring database for research purposes may make that information available to other entities for research purposes.

A state receiving a grant for a controlled substance monitoring program must: (1) facilitate prescriber and dispenser use of the state's controlled substance monitoring system, and (2) educate prescribers and dispensers on the benefits of the system.

This bill amends the Omnibus Crime Control and Safe Streets Act of 1968 to extend the Edward Byrne Memorial Justice Assistance Grant Program through FY2020.

HHS must advance education and awareness of the risk of abuse of prescription opioids (drugs with effects similar to opium).

The Office of National Drug Control Policy (ONDCP), in coordination with HHS and the DEA, must establish a national drug awareness campaign that emphasizes the similarities between heroin and prescription opioids.

The DEA, in coordination with HHS and ONDCP, may make grants to state, local, or tribal governments to create demonstration programs to allow first responders to prevent opioid overdose death by administering an opioid overdose reversal drug (e.g., naloxone).
What's happening now July 9, 2015

Referred to the Subcommittee on Crime, Terrorism, Homeland Security, and Investigations.

 Committees of jurisdiction 4
 Cosponsors 14
All 14 Democratic 9 Republican 5